Trial NCT04381936, ISRCTN50189673
Publication Horby P, Lancet, 2021 (published paper)
Dates: 2020-04-23 to 2021-01-24
Funding: Public/non profit (UK research and Innovation/National Institute for Health Research (NIHR); NIHR Oxford Biomedical Research Centre, Wellcome; Bill and Melinda Gates Foundation; Department for International Development; Health Data Research UK; Medical Research Council Population Health Research Unit; NIHR Clinical Trials Unit Support Funding; Abbvie (lopinavir-ritonavir); Roche Products Ltd (tocilizumab); Regeneron (REGEN-480 COV2))
Conflict of interest: No